Showing results (151-160 of 12,040) with videos related to

Sort By:
Pageof 1,204
Journal of Clinical Monitoring and Computing|September 6, 2002
Enamel nail polish does not interfere with pulse oximetry among normoxic volunteersThomas M Brand, Mary E Brand, Gregory D Jay
Orphanet Journal of Rare Diseases|October 1, 2018
Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?Malte Lenders, Boris Schmitz, Stefan-Martin Brand, et al.
European Journal of Human Genetics : EJHG|October 25, 2007
The impact of genetics and genomics on public healthAngela Brand, Helmut Brand, Tobias Schulte in den Bäumen
The Journal of Clinical Endocrinology and Metabolism|May 3, 2007
Rosiglitazone prevents free fatty acid-induced vascular endothelial dysfunctionFriedrich Mittermayer, Georg Schaller, Johannes Pleiner, et al.
The Journal of Clinical Endocrinology and Metabolism|August 10, 2006
Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetesDominik G Haider, Johannes Pleiner, Mario Francesconi, et al.
Calcified Tissue International|February 4, 2009
Treatment of osteoporosis with parathyroid hormone and teriparatideJohannes Pleiner-Duxneuner, Elisabeth Zwettler, Eleftherios Paschalis, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2004
Specific endothelin ET(A) receptor antagonism does not modulate insulin-induced hemodynamic effects in the human kidney, eye, or forearmAnna Rab, Susanne Dallinger, Kaija Polak, et al.
Shock (Augusta, Ga.)|November 20, 2003
Regulation of Fas (APO-1, CD95) and Fas ligand expression in leukocytes during systemic inflammation in humansClaudia Marsik, Thomas Halama, Francesco Cardona, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 27, 2008
Pioglitazone does not affect vascular or inflammatory responses after endotoxemia in humansG Schaller, J Kolodjaschna, J Pleiner, et al.
Pageof 1,204